CDC representatives have stated that doses of COVID-19 vaccines administered off label (outside of FDA/CDC/ACIP recommendations):
- may not be covered under the PREP Act as a countermeasure and vaccine providers may not have immunity from claims;
- those injured may not be eligible for compensation via the CICP;
- may not be reimbursed to providers by payers; and
- are a violation of the CDC provider agreement and may impact the ability of the provider to be a part of the provider program.